How High Will Roku Stock Go?
Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…
Buy
67
MDT Quote, Financials, Valuation and Earnings
Last price:
$87.28
Seasonality move
:
4.23%
Day range:
$87.65 - $88.53
52-week range:
$75.96 - $96.25
Dividend yield:
3.16%
P/E ratio:
24.44x
P/S ratio:
3.40x
P/B ratio:
2.36x
Volume:
5.9M
Avg. volume:
8M
1-year change:
7.61%
Market cap:
$113.4B
Revenue:
$33.5B
EPS (TTM):
$3.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MDT
Medtronic PLC
|
$8.8B | $1.58 | 5.71% | 53.44% | $95.43 |
|
ABT
Abbott Laboratories
|
$10.4B | $1.07 | 6.07% | 68.64% | $140.81 |
|
BSX
Boston Scientific
|
$4.6B | $0.67 | 18.78% | 229.3% | $117.02 |
|
ISRG
Intuitive Surgical
|
$2.2B | $1.73 | 16.8% | 32.43% | $575.49 |
|
SYK
Stryker
|
$5.7B | $2.73 | 9.23% | 43.28% | $421.46 |
|
TMDX
TransMedics Group
|
$123.4M | $0.24 | 28.29% | 22.47% | $129.57 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MDT
Medtronic PLC
|
$88.49 | $95.43 | $113.4B | 24.44x | $0.70 | 3.16% | 3.40x |
|
ABT
Abbott Laboratories
|
$136.45 | $140.81 | $237.4B | 17.70x | $0.59 | 1.67% | 5.63x |
|
BSX
Boston Scientific
|
$98.56 | $117.02 | $145.8B | 71.94x | $0.00 | 0% | 8.36x |
|
ISRG
Intuitive Surgical
|
$513.00 | $575.49 | $183.9B | 75.22x | $0.00 | 0% | 21.37x |
|
SYK
Stryker
|
$380.49 | $421.46 | $145.4B | 51.42x | $0.84 | 0.86% | 6.32x |
|
TMDX
TransMedics Group
|
$143.05 | $129.57 | $4.8B | 105.18x | $0.00 | 0% | 10.70x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MDT
Medtronic PLC
|
37.26% | 0.388 | 26.19% | 1.20x |
|
ABT
Abbott Laboratories
|
21.34% | 0.731 | 6.18% | 1.27x |
|
BSX
Boston Scientific
|
33.49% | 0.843 | 7.48% | 0.68x |
|
ISRG
Intuitive Surgical
|
-- | 1.668 | -- | 3.81x |
|
SYK
Stryker
|
44.5% | 1.087 | 12.02% | 0.80x |
|
TMDX
TransMedics Group
|
65.7% | 3.474 | 22.41% | 8.13x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MDT
Medtronic PLC
|
$5.8B | $1.8B | 6.12% | 9.51% | 16.08% | $2.1B |
|
ABT
Abbott Laboratories
|
$5.9B | $1.7B | 23.5% | 31.31% | 18.43% | $933M |
|
BSX
Boston Scientific
|
$3.2B | $937M | 6.35% | 9.57% | 19.02% | $277M |
|
ISRG
Intuitive Surgical
|
$1.5B | $578.1M | 15.82% | 15.82% | 25.66% | $465M |
|
SYK
Stryker
|
$3.7B | $872M | 8.33% | 14.2% | 14.87% | $127M |
|
TMDX
TransMedics Group
|
$88.2M | $27.4M | 6.8% | 23.22% | 21% | -$29.9M |
Medtronic PLC vs. Competitors
-
Which has Higher Returns MDT or ABT?
Abbott Laboratories has a net margin of 11.84% compared to Medtronic PLC's net margin of 12.79%. Medtronic PLC's return on equity of 9.51% beat Abbott Laboratories's return on equity of 31.31%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic PLC64.75% $0.82 $76.8B ABTAbbott Laboratories56.86% $0.76 $62.3B -
What do Analysts Say About MDT or ABT?
Medtronic PLC has a consensus price target of $95.43, signalling upside risk potential of 7.84%. On the other hand Abbott Laboratories has an analysts' consensus of $140.81 which suggests that it could grow by 3.2%. Given that Medtronic PLC has higher upside potential than Abbott Laboratories, analysts believe Medtronic PLC is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic PLC12 13 1 ABTAbbott Laboratories12 9 0 -
Is MDT or ABT More Risky?
Medtronic PLC has a beta of 0.793, which suggesting that the stock is 20.747% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.734, suggesting its less volatile than the S&P 500 by 26.647%.
-
Which is a Better Dividend Stock MDT or ABT?
Medtronic PLC has a quarterly dividend of $0.70 per share corresponding to a yield of 3.16%. Abbott Laboratories offers a yield of 1.67% to investors and pays a quarterly dividend of $0.59 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Abbott Laboratories pays out 28.62% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or ABT?
Medtronic PLC quarterly revenues are $8.9B, which are smaller than Abbott Laboratories quarterly revenues of $10.4B. Medtronic PLC's net income of $1.1B is lower than Abbott Laboratories's net income of $1.3B. Notably, Medtronic PLC's price-to-earnings ratio is 24.44x while Abbott Laboratories's PE ratio is 17.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.40x versus 5.63x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic PLC3.40x 24.44x $8.9B $1.1B ABTAbbott Laboratories5.63x 17.70x $10.4B $1.3B
-
Which has Higher Returns MDT or BSX?
Boston Scientific has a net margin of 11.84% compared to Medtronic PLC's net margin of 14.45%. Medtronic PLC's return on equity of 9.51% beat Boston Scientific's return on equity of 9.57%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic PLC64.75% $0.82 $76.8B BSXBoston Scientific68.84% $0.45 $33.6B -
What do Analysts Say About MDT or BSX?
Medtronic PLC has a consensus price target of $95.43, signalling upside risk potential of 7.84%. On the other hand Boston Scientific has an analysts' consensus of $117.02 which suggests that it could grow by 18.73%. Given that Boston Scientific has higher upside potential than Medtronic PLC, analysts believe Boston Scientific is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic PLC12 13 1 BSXBoston Scientific23 3 0 -
Is MDT or BSX More Risky?
Medtronic PLC has a beta of 0.793, which suggesting that the stock is 20.747% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.681, suggesting its less volatile than the S&P 500 by 31.908%.
-
Which is a Better Dividend Stock MDT or BSX?
Medtronic PLC has a quarterly dividend of $0.70 per share corresponding to a yield of 3.16%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or BSX?
Medtronic PLC quarterly revenues are $8.9B, which are larger than Boston Scientific quarterly revenues of $4.7B. Medtronic PLC's net income of $1.1B is higher than Boston Scientific's net income of $674M. Notably, Medtronic PLC's price-to-earnings ratio is 24.44x while Boston Scientific's PE ratio is 71.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.40x versus 8.36x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic PLC3.40x 24.44x $8.9B $1.1B BSXBoston Scientific8.36x 71.94x $4.7B $674M
-
Which has Higher Returns MDT or ISRG?
Intuitive Surgical has a net margin of 11.84% compared to Medtronic PLC's net margin of 30.99%. Medtronic PLC's return on equity of 9.51% beat Intuitive Surgical's return on equity of 15.82%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic PLC64.75% $0.82 $76.8B ISRGIntuitive Surgical64.69% $1.92 $17.2B -
What do Analysts Say About MDT or ISRG?
Medtronic PLC has a consensus price target of $95.43, signalling upside risk potential of 7.84%. On the other hand Intuitive Surgical has an analysts' consensus of $575.49 which suggests that it could grow by 12.18%. Given that Intuitive Surgical has higher upside potential than Medtronic PLC, analysts believe Intuitive Surgical is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic PLC12 13 1 ISRGIntuitive Surgical14 9 1 -
Is MDT or ISRG More Risky?
Medtronic PLC has a beta of 0.793, which suggesting that the stock is 20.747% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.875%.
-
Which is a Better Dividend Stock MDT or ISRG?
Medtronic PLC has a quarterly dividend of $0.70 per share corresponding to a yield of 3.16%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or ISRG?
Medtronic PLC quarterly revenues are $8.9B, which are larger than Intuitive Surgical quarterly revenues of $2.3B. Medtronic PLC's net income of $1.1B is higher than Intuitive Surgical's net income of $698.4M. Notably, Medtronic PLC's price-to-earnings ratio is 24.44x while Intuitive Surgical's PE ratio is 75.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.40x versus 21.37x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic PLC3.40x 24.44x $8.9B $1.1B ISRGIntuitive Surgical21.37x 75.22x $2.3B $698.4M
-
Which has Higher Returns MDT or SYK?
Stryker has a net margin of 11.84% compared to Medtronic PLC's net margin of 11.15%. Medtronic PLC's return on equity of 9.51% beat Stryker's return on equity of 14.2%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic PLC64.75% $0.82 $76.8B SYKStryker63.83% $1.69 $37.7B -
What do Analysts Say About MDT or SYK?
Medtronic PLC has a consensus price target of $95.43, signalling upside risk potential of 7.84%. On the other hand Stryker has an analysts' consensus of $421.46 which suggests that it could grow by 10.77%. Given that Stryker has higher upside potential than Medtronic PLC, analysts believe Stryker is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic PLC12 13 1 SYKStryker13 9 0 -
Is MDT or SYK More Risky?
Medtronic PLC has a beta of 0.793, which suggesting that the stock is 20.747% less volatile than S&P 500. In comparison Stryker has a beta of 0.914, suggesting its less volatile than the S&P 500 by 8.615%.
-
Which is a Better Dividend Stock MDT or SYK?
Medtronic PLC has a quarterly dividend of $0.70 per share corresponding to a yield of 3.16%. Stryker offers a yield of 0.86% to investors and pays a quarterly dividend of $0.84 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. Stryker pays out 40.73% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or SYK?
Medtronic PLC quarterly revenues are $8.9B, which are larger than Stryker quarterly revenues of $5.9B. Medtronic PLC's net income of $1.1B is higher than Stryker's net income of $654M. Notably, Medtronic PLC's price-to-earnings ratio is 24.44x while Stryker's PE ratio is 51.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.40x versus 6.32x for Stryker. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic PLC3.40x 24.44x $8.9B $1.1B SYKStryker6.32x 51.42x $5.9B $654M
-
Which has Higher Returns MDT or TMDX?
TransMedics Group has a net margin of 11.84% compared to Medtronic PLC's net margin of 17.89%. Medtronic PLC's return on equity of 9.51% beat TransMedics Group's return on equity of 23.22%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic PLC64.75% $0.82 $76.8B TMDXTransMedics Group61.47% $0.70 $776.4M -
What do Analysts Say About MDT or TMDX?
Medtronic PLC has a consensus price target of $95.43, signalling upside risk potential of 7.84%. On the other hand TransMedics Group has an analysts' consensus of $129.57 which suggests that it could fall by -9.42%. Given that Medtronic PLC has higher upside potential than TransMedics Group, analysts believe Medtronic PLC is more attractive than TransMedics Group.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic PLC12 13 1 TMDXTransMedics Group5 3 0 -
Is MDT or TMDX More Risky?
Medtronic PLC has a beta of 0.793, which suggesting that the stock is 20.747% less volatile than S&P 500. In comparison TransMedics Group has a beta of 2.097, suggesting its more volatile than the S&P 500 by 109.735%.
-
Which is a Better Dividend Stock MDT or TMDX?
Medtronic PLC has a quarterly dividend of $0.70 per share corresponding to a yield of 3.16%. TransMedics Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic PLC pays 76.98% of its earnings as a dividend. TransMedics Group pays out -- of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or TMDX?
Medtronic PLC quarterly revenues are $8.9B, which are larger than TransMedics Group quarterly revenues of $143.5M. Medtronic PLC's net income of $1.1B is higher than TransMedics Group's net income of $25.7M. Notably, Medtronic PLC's price-to-earnings ratio is 24.44x while TransMedics Group's PE ratio is 105.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic PLC is 3.40x versus 10.70x for TransMedics Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic PLC3.40x 24.44x $8.9B $1.1B TMDXTransMedics Group10.70x 105.18x $143.5M $25.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will The Trade Desk’s Stock Be in 5 Years?
If you stitched together every advertisement The Trade Desk (NASDAQ:…
Is MSTR Stock Fundamentally Misunderstood?
Software firm turned Bitcoin treasury Strategy (NASDAQ:MSTR) has made waves…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
20
KARO alert for Jun 13
Karooooo [KARO] is up 1.36% over the past day.
Sell
18
OXM alert for Jun 13
Oxford Industries [OXM] is down 8.31% over the past day.
Buy
69
MP alert for Jun 13
MP Materials [MP] is up 4.62% over the past day.
